Page 13 - Genomics Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Singular Genomics Systems to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to related businesses based on the strength of its valuation, analyst recommendations, institutional ownership, earnings, profitability, dividends and risk. Analyst Ratings This is […]

Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,760,000 shares, an increase of 43.8% from the March 15th total of 1,920,000 shares. Approximately 9.0% of the company’s shares are sold short. […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) had its target price decreased by The Goldman Sachs Group from $17.00 to $11.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 109.13% from the […]

Zacks Investment Research downgraded shares of Singular Genomics Systems (NASDAQ:OMIC – Get Rating) from a buy rating to a hold rating in a report published on Friday, Zacks.com reports. According to Zacks, “Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. […]